Claritin OTC
Selected indexed studies
- FDA approves OTC Claritin. (FDA Consum, 2003) [PMID:12625285]
- OTC loratadine. (Med Lett Drugs Ther, 2003) [PMID:12515952]
- OTC drugs for seasonal allergies. (Med Lett Drugs Ther, 2019) [PMID:31169808]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- OTC drugs for seasonal allergies. (2019) pubmed
- Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review. (2022) pubmed
- The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis--a meta-analysis. (2011) pubmed
- Therapeutic advantages of third generation antihistamines. (1998) pubmed
- OTC loratadine. (2003) pubmed
- OTC product: Loratadine for urticaria. (2005) pubmed
- The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. (2005) pubmed
- Therapeutic and economic consequences of OTC loratadine. (2004) pubmed
- The Rx-to-OTC switch of Claritin, Allegra, and Zyrtec: an unprecedented FDA response to petitioners and the protection of public health. (2002) pubmed
- FDA approves OTC Claritin. (2003) pubmed